Surgical Treatment for Macular Edema

References

• Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 1953;36:499–619
   Google Scholar
• Illif CE. Treatment of the vitreous-tug syndrome. Am J Ophthalmol 1966;62:856–859
   PubMedGoogle Scholar
• Tso MO. Pathology of cystoid macular edema. Ophthalmology 1982;89:902–915
   PubMedGoogle Scholar
• Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005;140:256–261
   PubMed Web of Science ®Google Scholar
• Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445–450
   PubMed Web of Science ®Google Scholar
• Cohen T, Nahari D, Cerem LW, et al. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736–741
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz JG. The blood–retinal barriers. Doc Ophthalmol 1976;41:287–327
   PubMed Web of Science ®Google Scholar
• Vane J, Botting R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1987;1:89–96
   PubMed Web of Science ®Google Scholar
• Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332–336
   PubMed Web of Science ®Google Scholar
• Taylor HR. LXIII Edward Jackson Memorial Lecture: eye care: Dollars and sense. Am J Ophthalmol 2007;143:1–8
   PubMedGoogle Scholar
• Tranos PG, Wickremasinghe SS, Stangos NT, et al. Macular edema. Surv Ophthalmol 2004;49:470–490
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Ikeda T, et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular oedema. Ophthalmology 2003;110:1690–1696
   PubMed Web of Science ®Google Scholar
• Harbour JW, Smiddy WE, Rubsamen PE, et al. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 1995;120:302–307
   PubMed Web of Science ®Google Scholar
• Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 2000;130:178–186
   PubMed Web of Science ®Google Scholar
• Watanabe M, Oshima Y, Emil K. Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation. Am J Ophthalmol 2000;129:264–267
   PubMedGoogle Scholar
• Kadonosono K, Itoh N, Ohno S. Perifoveal microcirculation before and after vitrectomy for diabetic cystoid macular edema. Am J Ophthalmol 2000;130:740–744
   PubMed Web of Science ®Google Scholar
• Kaiser PK, Reimann CD, Sears JE, Lewis H. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 2001;131:44–49
   PubMed Web of Science ®Google Scholar
• Schepens CL, Avila MP, Jalkh AE, Trempe CL. Role of the vitreous in cystoid macular edema. Surv Ophthalmol 1984;28(suppl):499–504
   PubMed Web of Science ®Google Scholar
• Gulkilik G, Kocabora S, Taskapili M, Engin G. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol 2006;41:699–703
   PubMed Web of Science ®Google Scholar
• Fung WE. Anterior vitrectomy for chronic aphakic cystoid macular edema. Ophthalmology 1980;87:189–193
   PubMedGoogle Scholar
• Fung WE. Vitrectomy for chronic aphakic cystoid macular edema. Results of a national, collaborative, prospective, randomized investigation. Ophthalmology 1985;92:1102–1111
   PubMed Web of Science ®Google Scholar
• Pendergast SD, Margherio RR, Williams GA, Cox MS Jr.. Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 1999;128:317–323
   PubMed Web of Science ®Google Scholar
• Peyman GA, Canakis C, Livir-Rallatos C, Conway MD. The effect of internal limiting membrane peeling on chronic recalcitrant pseudophakic cystoid macular edema: a report of two cases. Am J Ophthalmol 2002;133:571–572
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number. 1. Arch Ophthalmol 1985;103:1796–1806
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447–1459
   PubMed Web of Science ®Google Scholar
• Boyer DS, Faber D, Gupta S, et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011;31:915–923
   PubMed Web of Science ®Google Scholar
• , Diabetic Retinopathy Clinical Research NetworkElman MJ, Aiello LP, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064–1077
   PubMed Web of Science ®Google Scholar
• Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010;33:2399–2405
   PubMed Web of Science ®Google Scholar
• Mitchell P, Bandello F, Schmidt-Erfurth U, et al; RESTORE study group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615–625
   PubMed Web of Science ®Google Scholar
• Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous on the diabetic macular edema. Ophthalmology 1988;95:1335–1339
   PubMed Web of Science ®Google Scholar
• Sebag J, Balazs EA. Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 1984;28 Suppl:493–498
   PubMedGoogle Scholar
• Sebag J, Buckingham B, Charles MA, Reiser K. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 1992;110:1472–1476
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801–1815
   PubMed Web of Science ®Google Scholar
• Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753–759
   PubMed Web of Science ®Google Scholar
• Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW. Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol Scand 1999;77:170–175
   PubMedGoogle Scholar
• Hikichi T, Fujio N, Akiba J, et al. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 1997;104:473–478
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Yamamoto S, Takeuchi S. Pars plana vitrectomy for diabetic macular edema with posterior vitreous detachment. J Eye 2000;17:133–138
   Google Scholar
• Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996;122:258–260
   PubMed Web of Science ®Google Scholar
• Stefánsson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990;31(2):284–289
   PubMed Web of Science ®Google Scholar
• Christoforidis JB, D’Amico DJ. Surgical and other treatments of diabetic macular edema: an update. Int Ophthalmol Clin 2004;44:139–160
   PubMedGoogle Scholar
• , Diabetic Retinopathy Clinical Research Network Writing CommitteeHaller JA, Qin H, et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 2010;117(6):1087–1093
   PubMed Web of Science ®Google Scholar
• Kumagai K, Furukawa M, Ogino N, et al. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina 2009;29:464–472
   PubMed Web of Science ®Google Scholar
• Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edemal. Am J Ophthalmol 2005;139:447–454
   PubMed Web of Science ®Google Scholar
• Stolba U, Binder S, Gruber D, et al. Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 2005;140:295–301
   PubMed Web of Science ®Google Scholar
• Stefaniotou M, Aspiotis M, Kalogeropoulos C, et al. Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 2004;14:137–143
   PubMedGoogle Scholar
• Bahadir M, Ertan A, Mertoğlu O. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol 2005;26(1–2):3–8
   PubMedGoogle Scholar
• Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000;20:126–133
   PubMed Web of Science ®Google Scholar
• Matsunaga N, Ozeki H, Hirabayashi Y, et al. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 2005;25:311–316
   PubMed Web of Science ®Google Scholar
• Radetzky S, Walter P, Fauser S, et al. Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2004;242:273–278
   PubMed Web of Science ®Google Scholar
• Stefánsson E. Therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 2001;79:435–440
   PubMedGoogle Scholar
• Uckermann O, Uhlmann S, Pannicke T, et al. Ischemia-reperfusion causes exudative detachment of the rabbit retina. Invest Ophthalmol Vis Sci 2005;46:2592–2600
   PubMedGoogle Scholar
• Stefánsson E. Physiology of vitreoussurgery. Graefes Arch Clin Exp Ophthalmol 2009;247(2):147–163
   PubMed Web of Science ®Google Scholar
• Gandorfer A, Rohleder M, Grosselfinger S, et al. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 2005;139:638–652
   PubMed Web of Science ®Google Scholar
• Sonada KH, Sakamoto T, Enaida H, et al. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 2004;111:226–230
   PubMedGoogle Scholar
• Hoerauf H, Brüggemann A, Muecke M, et al. Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial. Graefes Arch Clin Exp Ophthalmol 2011;249:997–1008
   PubMed Web of Science ®Google Scholar
• Augustin AJ, Spitznas M, Koch F, et al. Indications of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ger J Ophthalmol 1995;4:47–51
   PubMedGoogle Scholar
• Goldenberg DT, Hassan TS. Small gauge, sutureless surgery techniques for diabetic vitrectomy. Int Ophthalmol Clin 2009;49:141–151
   PubMedGoogle Scholar
• Park DH, Shin JP, Kim SY. Comparison of clinical outcomes between 23-gauge and 20-gauge vitrectomy in patients with proliferative diabetic retinopathy. Retina 2010;30:1662–1670
   PubMed Web of Science ®Google Scholar
• Yang SJ, Yoon SY, Kim JG, Yoon YH. Transconjunctival sutureless vitrectomy for the treatment of vitreoretinal complications in patients with diabetes mellitus. Ophthalmic Surg Lasers Imaging 2009;40:461–466
   PubMedGoogle Scholar
• Oshima Y, Wakabayashi T, Sato T, et al. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology 2010;117:93–102
   PubMed Web of Science ®Google Scholar
• Kang SW, Park SC, Cho HY, Kang JH. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema. Am J Ophthalmol 2007;144:878–885
   PubMed Web of Science ®Google Scholar
• Mochizuki Y, Hata Y, Enaida H, et al. Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema. Retina 2006;26:143–148
   PubMed Web of Science ®Google Scholar
• Lopez-Lopez F, Rodriguez-Blanco M, Gomez-Ulla F, Marticorena J. Enzymatic vitreolysis. Curr Diabetes Rev 2009;5:57–62
   PubMedGoogle Scholar
• Benz MS, Packo KH, Gonzalez V, et al. A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy. Ophthalmology 2010;117:791–797
   PubMed Web of Science ®Google Scholar
• Diaz-Llopis M, Udaondo P, Arevalo F, et al. Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema. J Ocul Pharmacol Ther 2009;25:379–384
   PubMed Web of Science ®Google Scholar
• Grigorian R, Bhagat N, Lanzetta P, et al. Pars plana vitrectomy for refractory diabetic macular edema. Semin Ophthalmol 2003;18:116–120
   PubMedGoogle Scholar
• Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408–415
   PubMed Web of Science ®Google Scholar
• Opremcak EM, Mitchel E, Rehmar AJ, et al. Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases. Retina 2006;26:297–305
   PubMedGoogle Scholar
• Opremcak EM, Rehmar AJ, Ridenour CD, et al. Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases. Retina 2006;26:306–313
   PubMedGoogle Scholar
• Hasselbach HC, Ruefer F, Feltgen N, et al. Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases. Graefes Arch Clin Exp Ophthalmol 2007;245:1145–1156
   PubMedGoogle Scholar
• Nomoto H, Shiraga F, Yamaji H, et al. Evaluation of radial optic neurotomy for central retinal vein occlusion by indocyanine green videoangiography and image analysis. Am J Ophthalmol 2004;138:612–619
   PubMedGoogle Scholar
• Spaide RF, Klancnik JM Jr., Gross NE. Retinal choroidal collateral circulation after radial optic neurotomy correlated with the lessening of macular edema. Retina 2004;24:356–359
   PubMedGoogle Scholar
• Williamson TH, Poon W, Whitefield L, et al. A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ischaemic central retinal vein occlusion. Br J Ophthalmol 2003;87:1126–1129
   PubMedGoogle Scholar
• Fortunato P, Pollazzi L, Baroni M, et al. Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2010;248:167–173
   PubMedGoogle Scholar
• Furino C, Ferrari TM, Boscia F, et al. Combined radial optic neurotomy, internal limiting membrane peeling, and intravitreal triamcinolone acetonide for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:422–425
   PubMedGoogle Scholar
• Arevalo JF, Garcia RA, Wu L, et al. Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES). Retina 2008;28:1044–1052
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Management of central retinal vein occlusion. Ophthalmologica 2003;217:167–188
   PubMed Web of Science ®Google Scholar
• Horio N, Horiguchi M. Retinal blood flow and macular edema after radial optic neurotomy for central retinal vein occlusion. Am J Ophthalmol 2006;141:31–34
   PubMedGoogle Scholar
• Friberg TR, Smolinski P, Hill S, Kurup SK. Biomechanical assessment of radial optic neurotomy. Ophthalmology 2008;115(1):174–180
   PubMedGoogle Scholar
• D'Amico DJ, Lit ES, Viola F. Lamina puncture for central retinal vein occlusion: results of a pilot trial. Arch Ophthalmol 2006;124:972–977
   PubMedGoogle Scholar
• Sharma A, D’Amico DJ. Medical and surgical management of central retinal vein occlusion. Int Ophthalmol Clin 2004;44:1–16
   PubMedGoogle Scholar
• McAllister IL, Douglas JP, Constable IJ, Yu DY. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998;126:219–229
   PubMed Web of Science ®Google Scholar
• McAllister IL, Gillies ME, Smithies LA, et al. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology 2010;117:954–965
   PubMed Web of Science ®Google Scholar
• Koizumi K, Nishiura M, Yamamoto T, et al. Intentional complete interruption of a retinal vein after vitrectomy might improve the rate of successful chorioretinal venous anastomosis formation in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:787–794
   PubMedGoogle Scholar
• Mirshahi A, Roohipoor R, Lashay A, et al. Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial. Br J Ophthalmol 2005;89:64–69
   PubMedGoogle Scholar
• Quiroz-Mercado H, Sánchez-Buenfil E, Guerrero-Naranjo JL, et al. Successful erbium: YAG laser-induced chorioretinal venous anastomosis for the management of ischemic central retinal vein occlusion. A report of two cases. Graefes Arch Clin Exp Ophthalmol 2001;239:872–875
   PubMedGoogle Scholar
• Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249–2257
   PubMed Web of Science ®Google Scholar
• Feltgen N, Junker B, Agostini H, Hansen LL. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 2007;114:716–723
   PubMed Web of Science ®Google Scholar
• Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusion. Arch Ophthalmol 1988;106:1469–1471
   PubMedGoogle Scholar
• García-Arumí J, Martinez-Castillo V, Boixadera A, et al. Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina 2004;24:530–540
   PubMed Web of Science ®Google Scholar
• Avci R, Inan UU, Kaderli B. Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion. Eye (Lond) 2008;22:120–127
   PubMed Web of Science ®Google Scholar
• Chung EJ, Lee H, Koh HJ. Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:967–974
   PubMed Web of Science ®Google Scholar
• Oh IK, Kim S, Oh J, Huh K. Long-term visual outcome of arteriovenous adventitial sheathotomy on branch retinal vein occlusion induced macular edema. Korean J Ophthalmol 2008;22:1–5
   PubMedGoogle Scholar
• Liang XL, Chen HY, Huang YS, et al. Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study. Ann Acad Med Singapore 2007;36:293–297
   PubMed Web of Science ®Google Scholar
• Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina 2004;24:348–355
   PubMed Web of Science ®Google Scholar
• Park DH, Kim IT. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina 2010;30:117–124
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Ikeda T, et al. Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Ophthalmol 2003;135:321–327
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Sakata K, et al. Macular microcirculation before and after vitrectomy for macular edema with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2010;248:443–445
   PubMedGoogle Scholar
• Saika S, Tanaka T, Miyamoto T, Ohnishi Y. Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 2001;239:729–732
   PubMed Web of Science ®Google Scholar
• Zimmerman PL. Pars planitis and other intermediate uveitis. In: Ophthalmology. Yanoff M, Duker JS, eds. St Louis, MO: Mosby Elsevier, 1999. pp 10.1–10.6
   Google Scholar
• Heiligenhaus A, Bornfeld N, Wessing A. Long-term results of pars plana vitrectomy in the management of intermediate uveitis. Curr Opin Ophthalmol 1996;7(3):77–79
   PubMedGoogle Scholar
• Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol 2005;140:1096–1105
   PubMed Web of Science ®Google Scholar
• Garweg JG, Becker M, Lommatzsch A, Bartz-Schmidt KU. Update on vitrectomy for pediatric uveitis [in German]. Klin Monbl Augenheilkd 2007;224:538–542
   PubMedGoogle Scholar
• Gutfleisch M, Spital G, Mingels A, et al. Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations. Br J Ophthalmol 2007;91:345–348
   PubMed Web of Science ®Google Scholar
• Schaal S, Tezel TH, Kaplan HJ. Surgical intervention in refractory CME–role of posterior hyaloid separation and internal limiting membrane peeling. Ocul Immunol Inflamm 2008;16:209–210
   PubMed Web of Science ®Google Scholar
• Tranos P, Scott R, Zambarajki H, et al. The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study. Br J Ophthalmol 2006;90:1107–1110
   PubMed Web of Science ®Google Scholar
• Liversidge J, Dick A, Cheng YF, et al. Retinal antigen specific lymphocytes, TCR-gamma delta T cells and CD5+ B cells cultured from the vitreous in acute sympathetic ophthalmitis. Autoimmunity 1993;15:257–266
   PubMed Web of Science ®Google Scholar
• Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:24–31
   PubMed Web of Science ®Google Scholar
• Muhaya M, Calder VL, Towler HM, et al. Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol 1999;116:410–414
   PubMed Web of Science ®Google Scholar
• Markomichelakis NN, Halkiadakis I, Pantelia E, et al. Course of macular edema in uveitis under medical treatment. Ocul Immunol Inflamm 2007;15:71–79
   PubMed Web of Science ®Google Scholar
• Uchino E, Uemura A, Ohba N. Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol 2001;119:1475–1479
   PubMedGoogle Scholar
• Gass JD. Macular dysfunction caused by vitreous and vitreoretinal interface abnormalities. In: Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Gass JD, ed. 4th ed. St. Louis, MO: Year Book Inc., 1997. pp 903–914
   Google Scholar
• Hikichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome. Am J Ophthalmol 1995;119:55–61
   PubMed Web of Science ®Google Scholar
• McDonald HR, Johnson RN, Schatz H. Surgical results in the vitreomacular traction syndrome. Ophthalmology 1994;101:1397–1403
   PubMedGoogle Scholar
• Smiddy WE, Michels RG, Glaser BM, de Bustros S. Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol 1988;106:624–628
   PubMedGoogle Scholar
• Witkin AJ, Ko TH, Fujimoto JG, et al. Vitreofoveal attachment causing metamorphopsia: an ultrahigh-resolution optical coherence tomography finding. Retina 2006;26:1085–1087
   PubMedGoogle Scholar
• Yamada N, Kishi S. Tomographic features and surgical outcomes of vitreomacular tractional syndrome. Am J Ophthalmol 2005;139:112–117
   PubMed Web of Science ®Google Scholar
• Gass JD. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995;119:752–759
   PubMed Web of Science ®Google Scholar
• Johnson RN, Gass JD. Idiopathic macular holes: observations, stages of formation, and implications for surgical intervention. Ophthalmology 1988;95:917–924
   PubMed Web of Science ®Google Scholar
• Gallemore RP, Jumper JM, McCuen BW 2nd, et al. Diagnosis of vitreoretinal adhesions in macular disease with optical coherence tomography. Retina 2000;20:115–120
   PubMed Web of Science ®Google Scholar
• Do DV, Cho M, Nguyen QD, et al. The impact of optical coherence tomography on surgical decision making in epiretinal membrane and vitreomacular traction. Trans Am Ophthalmol Soc 2006;104:161–166
   PubMedGoogle Scholar
• Johnson MW. Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc 2005;103:537–567
   PubMedGoogle Scholar
• Witkin AJ, Patron ME, Castro LC, et al. Anatomic and visual outcomes of vitrectomy for vitreomacular traction syndrome. Ophthalmic Surg Lasers Imaging 2010;41:425–431
   PubMedGoogle Scholar
• de Smet MD, Valmaggia C, Zarranz-Ventura J, Willekens B. Microplasmin: ex vivo characterization of its activity in porcine vitreous. Invest Ophthalmol Vis Sci 2009;50:814–819
   PubMed Web of Science ®Google Scholar
• de Smet MD, Gandorfer A, Stalmans P, et al. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial. Ophthalmol 2009;116:1349–1355
   PubMed Web of Science ®Google Scholar
• Stalmans P, Delaey C, de Smet MD, et al. Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial). Retina 2010;30:1122–1127
   PubMed Web of Science ®Google Scholar
• Margherio RR, Cox MS Jr., Trese MT, et al. Removal of epimacular membranes. Ophthalmology 1985;92:1075–1083
   PubMed Web of Science ®Google Scholar
• Pesin SR, Olk RJ, Grand MG, et al. Vitrectomy for premacular fibroplasia. Prognostic factors, long-term follow-up, and time course of visual improvement. Ophthalmology 1991;98:1109–1114
   PubMed Web of Science ®Google Scholar
• Rice TA, De Bustros S, Michels RG, et al. Prognostic factors in vitrectomy for epiretinal membranes of the macula. Ophthalmology 1986;93:602–610
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Kovacs KD, Wagley S, Arroyo JG. Morphologic differences in epiretinal membranes on ocular coherence tomography as a predictive factor for surgical outcome. Retina 2011;31:1692–1698
   PubMed Web of Science ®Google Scholar
• Pendergast SD. Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloid. Curr Opin Ophthalmol 1998;9:71–75
   PubMedGoogle Scholar
• Au Eong KG, Fujii GY, de Juan E Jr., et al. A new three-port cannular system for closed pars plana vitrectomy. Retina 2002;22:130–132
   PubMedGoogle Scholar